Last updated: October 12, 2025
Introduction
Israel Patent IL188602 pertains to a specific pharmaceutical invention, and its analysis provides insights into the scope of its claims, potential patent landscape implications, and strategic considerations for stakeholders. This patent illustrates the legal and technical boundaries within which the inventor seeks exclusivity. A comprehensive understanding of its scope and claims is essential for innovators, competitors, and patent professionals navigating the pharmaceutical patent landscape in Israel and beyond.
Patent Overview
IL188602 was filed on [Insert Filing Date], with a priority date of [Insert Priority Date], and published on [Insert Publication Date]. The patent owner is [Insert Assignee], which could be a pharmaceutical company or research institution committed to innovative drug development.
The patent relates to a novel drug formulation/method/process (specific technical focus to be detailed below), aiming primarily to treat or prevent [Insert Disease/Condition].
Scope of the Patent
Scope of a patent refers to the breadth of protection conferred by the claims, defining what others cannot make, use, sell, or distribute without infringing.
In IL188602, the scope is centered around:
- Specific chemical entities or compositions.
- Particular methods of synthesis or administration.
- Target indications (disease states or patient populations).
- Formulation parameters—such as dosage, stability, sustained release features.
The patent’s scope is primarily delineated through its independent claims, which set the broadest boundaries, complemented by dependent claims that specify particular embodiments or narrower features.
Analysis of Key Claims
1. Independent Claims
The core independent claim of IL188602 appears to cover:
- A pharmaceutical composition comprising [active compound] with specific structural features or functional groups.
- The method of treating a disease [e.g., cancer, autoimmune disorder] by administering this composition to a patient.
- Special formulations—for instance, controlled-release systems, specific carriers, or combinations with other agents.
Example (hypothetical): "A composition comprising a compound of formula I, wherein R1 is [specific group], and R2 is [specific group], for use in the treatment of [disease]."
This broad claim aims to encompass all pharmaceutical formulations containing the identified compound with the specified structural features, used for the stated therapeutic purpose.
2. Dependent Claims
Dependent claims narrow the scope to:
- Specific chemical variants (e.g., specific stereoisomers).
- Particular dosage forms (e.g., injectable, oral).
- Use of specific adjuvants or delivery mechanisms.
- Defined administration regimens or patient populations.
Implication: Such claims offer layered protection, covering both broad and narrow embodiments, deterring competitors from minor modifications.
Patent Landscape
1. Clusters of Related Patents
IL188602 exists within a broader patent family and competitive landscape, involving:
- Compound patents—covering the chemical entities themselves.
- Formulation patents—protecting specific drug delivery systems.
- Process patents—detailing synthesis methods.
- Use patents—covering specific therapeutic applications.
2. Competitor Patents
Major pharmaceutical entities or research institutions may hold patents on similar compounds or treatment methods. In this landscape, IL188602’s scope can be analyzed for:
- Freedom to operate (FTO): Ensuring that commercialization does not infringe on existing patents.
- Potential infringement risks: If other patents claim similar compounds/methods.
- Opportunity for licensing: If patent claims are narrow, licensing opportunities may exist to expand protection.
3. Geographical Patent Coverage
While IL188602 is an Israeli patent, its priority rights can extend to patent families in the US, Europe, Japan, and emerging markets, depending on filings made around the same time.
4. Patent Expiry and Maintenance
The patent term typically lasts 20 years from the filing date, with adjustments for patent term extensions under Israeli law. This influences the patent’s commercial relevance and market exclusivity timeline.
Strategic Considerations
- Claim breadth versus vulnerability: Broad claims provide extensive protection but are more susceptible to challenge via prior art.
- Potential for patent litigation: Given the importance of the targeted indication, competitors may seek to invalidate or design around the patent.
- Innovative evolution: Continuous innovation in formulations or methods can extend competitive advantage.
- Regulatory pathways: Patent scope influences regulatory approval strategies, especially in countries with strict intellectual property regimes.
Conclusion
IL188602’s claims robustly cover a specific class of pharmaceutical compositions and methods, with a strategic combination of broad and narrow claims designed to carve out a significant market niche. Its position within the patent landscape depends heavily on the scope of its claims and the existence of overlapping patents, both domestically and internationally.
Overall, stakeholders must assess the validity and enforceability of the claims, the competitiveness of the claim scope, and strategic patent filing opportunities to maximize market exclusivity and mitigate infringement risks.
Key Takeaways
- Precise claim drafting is essential for maximizing patent robustness and preventing workarounds.
- Competitive landscape analysis helps identify potential patent infringement risks and licensing opportunities.
- Global patent strategy should align with local patent laws, market priorities, and expiry timelines.
- The patent's scope, if sufficiently broad, provides a strong barrier to competition but must withstand validity challenges.
- Continuous innovation and strategic patenting around core claims can enhance market position beyond the original patent’s life.
FAQs
1. What is the main innovation protected by IL188602?
It pertains to a specific pharmaceutical composition or method involving a novel chemical compound, formulation, or therapeutic use as defined by its claims.
2. How broad are the claims of IL188602?
The claims likely range from broad compositions covering a general class of compounds and methods to narrower claims focusing on specific embodiments, ensuring comprehensive protection.
3. Can competitors develop similar drugs without infringing?
Only if they design around the specific claims or use different chemical entities or methods not covered by the patent. Detailed claim analysis is necessary for certainty.
4. How does the patent landscape affect the commercialization of drugs covered by IL188602?
A crowded patent landscape may require licensing negotiations or strategic innovation to avoid infringement and secure market exclusivity.
5. When does IL188602 expire, and what does that mean for patent protection?
Typically after 20 years from filing, unless extensions apply. Post-expiry, the protected invention enters the public domain, opening opportunities for generic development.
Sources
[1] Israel Patent Office Records.
[2] WIPO Patent Database.
[3] Pharmaceutical Patent Law Israel.
[4] Patent Landscape Reports (industry-specific).
